MedPath

Fluid Oriented Therapy During Major Abdominal Surgery

Not Applicable
Completed
Conditions
Goal Directed Therapy
Interventions
Device: FloTrac
Registration Number
NCT03023618
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

In this "before and after" study we will investigate the potential benefit on postoperative outcomes of a guided fluid therapy with a stroke volume optimization . The NICE protocol has been applied by means of EV1000 monitor and arterial waveform analysis ( Flotrac - Edwards). In the postoperative period overall complications, as well as exitus , will be analyzed and compared with those of a control group underwent the same surgical interventions, with a standard hemodynamic monitoring.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
180
Inclusion Criteria
  • ASA 1-2 patients
Exclusion Criteria
  • Severe Caridiac Disease
  • Renal Failure

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
case groupFloTracpatients after 2014, after management of fluid therapy has been guided by FloTrac parameters as a standard clinical practice (NICE protocol)
Primary Outcome Measures
NameTimeMethod
complication rateup to 30 days postoperatively
Secondary Outcome Measures
NameTimeMethod
Duration of hospitalizationan average of 30 days
© Copyright 2025. All Rights Reserved by MedPath